• H. Dunbar Hoskins Jr., MDThe H. Dunbar Hoskins Jr., M.D. Center for Quality Eye Care was established as a quality of care and health policy research center that advances the accessibility to and appropriateness of eye care services. The work of the Hoskins Center will help ensure that patients continue to receive high quality, evidence-based eye care within a tightening economic environment that demands increased value for services provided.

  • from AAO OTAC Glaucoma Panel, Hoskins Center for Quality Eye Care
    Intravitreal injection of anti-VEGF agents results in an immediate and transient increase in IOP. A long-term increase in IOP also may be seen. Further studies are needed to determine at-risk populations and to determine the impact on glaucoma progression.
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Orthokeratology may be effective in slowing myopic progression for children and adolescents, with a potentially greater effect when initiated at an early age (6–8 years). Safety remains a concern because of the risk of potentially blinding microbial keratitis.
    Ophthalmic Technology Assessment
    from AAO PPP Cornea/External Disease Committee, Hoskins Center for Quality Eye Care
    Evidence-based update using Cochrane Eyes and Vision Group-identified systematic reviews detailing recommendations for the initial evaluation and treatment of a patient with dry eye and a detailed discussion of diagnostic tests.
    Preferred Practice Pattern Guideline
    from AAO PPP Cornea/External Disease Committee, Hoskins Center for Quality Eye Care
    Evidence-based update using Cochrane Eyes and Vision Group-identified systematic reviews detailing recommendations for the initial evaluation of a patient with presumed blepharitis, and for diagnostic tests and treatment.
    Preferred Practice Pattern Guideline
    from AAO PPP Cornea/External Disease Committee, Hoskins Center for Quality Eye Care
    Evidence-based update using Cochrane Eyes and Vision Group-identified systematic reviews for the initial evaluation, diagnosis, and management of post-LASIK and other corneal ectasias, including a discussion of existing and emerging surgical treatments.
    Preferred Practice Pattern Guideline
    from AAO PPP Cornea/External Disease Committee, Hoskins Center for Quality Eye Care
    Evidence-based update using Cochrane Eyes and Vision Group-identified systematic reviews for the initial evaluation of conjunctivitis patients and discussion of associated or predisposing factors, the natural history of each type of conjunctivitis and treatment recommendatio…
    Preferred Practice Pattern Guideline
    from AAO PPP Cornea/External Disease Committee, Hoskins Center for Quality Eye Care
    Evidence-based update using Cochrane Eyes and Vision Group-identified systematic reviews for the initial evaluation and diagnosis of corneal edema and corneal opacification. Management approaches for edema and opacification, including surgical approaches, are discussed separ…
    Preferred Practice Pattern Guideline
    from AAO PPP Cornea/External Disease Committee, Hoskins Center for Quality Eye Care
    Evidence-based update using Cochrane Eyes and Vision Group-identified systematic reviews on the diagnosis and management of bacterial keratitis. It contains detailed recommendations for the initial evaluation of a patient with presumed bacterial keratitis, and for diagnostic…
    Preferred Practice Pattern Guideline
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    There is limited evidence to support the safety and efficacy of β-blockers to promote regression of periocular hemangiomas. Additional research may confirm the best dosage and route of administration to maximize efficacy while minimizing side effects.
    Ophthalmic Technology Assessment
    from AAO OTAC Retina/Vitreous Panel, Hoskins Center for Quality Eye Care
    Review of the literature indicates that intravitreal injection of anti-VEGF therapy is safe and effective for neovascular AMD over 2 years. Further research is needed to evaluate long-term safety and comparative efficacy of these agents.
    Ophthalmic Technology Assessment
    from From American Academy of Optometry and American Academy of Ophthalmology Hoskins Center for Quality Eye Care
    This statement applies to anyone who may consider getting contact lenses without a proper prescription and/or without proper contact lens care. Risks include corneal abrasions, corneal ulcers and potentially vision-threatening infections.
    Clinical Statement
    from AAO OTAC Glaucoma Panel, Hoskins Center for Quality Eye Care
    Structural glaucomatous damage can be detected by SD OCT. Optic nerve, RNFL, and macular parameters can help the clinician distinguish the anatomic changes that are associated with patients with glaucoma when compared with normal subjects.
    Ophthalmic Technology Assessment
    from Council on Child Abuse and Neglect, Section on Ophthalmology; American Association of Certified Orthoptists; American Association for Pediatric Ophthalmology and Strabismus; and American Academy of Ophthalmology
    This clinical report recommends that physicians consider abuse in the differential diagnosis of pediatric eye trauma. A thorough eye examination is required, including indirect ophthalmoscopy through a dilated pupil for the evaluation of possible retinal hemorrhages.
    Clinical Statement
    from AAO OTAC Glaucoma Panel, Hoskins Center for Quality Eye Care
    LPI increases angle width in all stages of PAC and has a good safety profile. Most PACS eyes do not receive further intervention, whereas many PAC and APAC eyes, and most PACG eyes, receive further treatment.
    Ophthalmic Technology Assessment
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    The literature indicates that balloon dacryoplasty is a safe, effective procedure to address congenital nasolacrimal duct obstruction that persists after standard probings. The outcomes of this intervention are similar to those of lacrimal stenting.
    Ophthalmic Technology Assessment
    from AAO Hoskins Center for Quality Eye Care
    Patients in the hospital may experience ocular conditions, e.g., pain, redness and visual loss, or manifestation of their systemic disease. Medical personnel should not hesitate to seek an ophthalmologist’s evaluation and guidance when appropriate for their patients.
    Clinical Statement
    from AAO OTAC Oculoplastics and Orbit Panel, Hoskins Center for Quality Eye Care
    Botox, Meditoxin, and Xeomin are effective for the treatment of BEB. Meditoxin and Botox have equivalent effectiveness and incidence of adverse events for BEB and HFS. Higher doses of Botox and Dysport result in more adverse events.
    Ophthalmic Technology Assessment
    from AAO OTAC Pediatric Ophthalmology/Strabismus Panel, Hoskins Center for Quality Eye Care
    Silicone elastomer and RGP contact lenses were found to be effective for treating aphakia in children, although evidence was limited. The choice of which lens a practitioner prescribes should be based on the particular needs of each patient.
    Ophthalmic Technology Assessment
    from ASCRS, OOSS, AAO Hoskins Center for Quality Eye Care
    These guidelines are intended to assist ambulatory surgery centers (ASCs) in their efforts to adopt appropriate practices for the cleaning and sterilization of intraocular surgical instruments. They are provided for scientific, educational, and informational purposes only.
    Clinical Statement
    from AAO Telemedicine Task Force
    This statement provides an overview of telemedicine for ophthalmology and highlights issues that will shape the development and implementation of telemedicine for ophthalmology in the near future.
    Clinical Statement